Hunt Jonathan Robert
SEC insider (Form 3/4/5 filer). CIK 0001375410. Chief Accounting Officer at Perspective Therapeutics, Inc. (CATX). 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in SEATTLE, WA.
Companies Hunt Jonathan Robert has filed insider reports for
- Perspective Therapeutics, Inc. (CATX): Officer, Chief Accounting Officer
Hunt Jonathan Robert
CIK: 0001375410
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Perspective Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Mar 2, 2026CATX
Perspective Therapeutics, Inc.
AwardDirectStock option (right to buy)
90K shares- - Nov 13, 2025CATX
Perspective Therapeutics, Inc.
PurchaseDirect11K shares at avg. $2.03$22K - Mar 3, 2025CATX
Perspective Therapeutics, Inc.
AwardDirectStock option (right to buy)
75K shares- - Nov 25, 2024CATX
Perspective Therapeutics, Inc.
PurchaseDirect10K shares at avg. $3.88$39K - Nov 25, 2024CATX
Perspective Therapeutics, Inc.
PurchaseDirect2.4K shares at avg. $3.60$9K - Nov 25, 2024CATX
Perspective Therapeutics, Inc.
PurchaseDirect400 shares at avg. $3.55$1K - Nov 25, 2024CATX
Perspective Therapeutics, Inc.
PurchaseDirect29 shares at avg. $3.94$114.26
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | CATX Perspective Therapeutics, Inc. | Award Stock option (right to buy) | 90,000 | - | - | Direct |
| Nov 13, 2025 | CATX Perspective Therapeutics, Inc. | Purchase | 11,000 | $2.03 | $22,295 | Direct |
| Mar 3, 2025 | CATX Perspective Therapeutics, Inc. | Award Stock option (right to buy) | 75,000 | - | - | Direct |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Purchase | 10,000 | $3.88 | $38,800 | Direct |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Purchase | 2,400 | $3.60 | $8,640 | Direct |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Purchase | 400 | $3.55 | $1,420 | Direct |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Purchase | 29 | $3.94 | $114 | Direct |
1-7 of 7 transactions